Skip to main content

Respiratory Syncytial Virus clinical trials at UC Davis

3 research studies open to eligible people

Showing trials for
  • A Clinical Study for Infants and Toddlers Diagnosed with Respiratory Syncytial Virus (RSV)

    “Volunteer for research and contribute to discoveries that may improve health care for you, your family, and your community!”

    open to eligible people ages up to 36 months

    A 2-part study to evaluate the safety, pharmacokinetics and efficacy of EDP-938 in children with RSV infection.

    Sacramento, California and other locations

  • A Study of RV521 in the Treatment of Adult Subjects With an Upper Respiratory Tract Infection

    open to eligible people ages 18-75

    RV521 is to being developed to treat RSV infection and disease in susceptible individuals at high risk for complications. This is an international, multicenter, placebo-controlled study. Eligible subjects are adults with a documented symptomatic RSV infection who have undergone HCT transplantation and are moderately to severely immunocompromised. Qualified subjects will be randomized in a 1:1 ratio to receive RV521 or placebo, twice daily for 10 days.

    Sacramento, California and other locations

  • Are you pregnant? Participate in a vaccine study trying to protect babies from Respiratory Syncytial Virus!

    “Pass on what's important: You’ll give them love in lots of ways. Could protection from RSV be one of them?”

    open to eligible females ages up to 49 years

    This randomized, double-blinded, placebo-controlled Phase 3 study is designed to evaluate the efficacy and safety of maternal immunization with RSVpreF against medically attended lower respiratory tract illness (MA-LRTI) in infants.

    Sacramento, California and other locations

Last updated: